About Ace Pharmaceuticals Belgium
Ace Pharmaceuticals Belgium is a private limited company (BV/SRL) based in Sint-Martens-Latem, founded in 2019. Its main activity is classified as "Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied". For the 2025 financial year, Ace Pharmaceuticals Belgium reported a profit of €231,722. That makes 5 profitable financial years in a row for Ace Pharmaceuticals Belgium. Revenue was not published, which is common for abbreviated accounts. The gross margin came to €531,961, up 93% on 2024. It employed an average of 1 full-time equivalent. Equity stands at €410,226, a solvency ratio of 26%. In 2020 it was €26,968. 6 annual accounts are available, covering 2020 to 2025.
- Sectors
- Wholesalers
- Signals
-
Poor liquidityPoor liquidity 0.82
The current ratio is below 1: may be insufficient to cover short-term debt.
ProfitableProfitable € 232KThe company reported a positive net result in the latest financial year.
Strong equityStrong equity € 410KStrong equity provides a buffer against setbacks.
Positive cashflowPositive cashflow € 298KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 408KPositive EBITDA: operating activities are profitable.
Healthy social debtHealthy social debt 11.7%Social debts stay manageable relative to personnel costs.
- Directors
- Tlys Scs, Amberste Holding Bv, Ronald Feiter Cornelis, +1 more
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
532K
|
€
276K
|
€
150K
|
€
140K
|
|
|
€
408K
|
€
169K
|
€
44K
|
€
33K
|
|
|
€
232K
|
€
54K
|
€
2K
|
€
17K
|
|
|
€
410K
|
€
179K
|
€
125K
|
€
123K
|
|
|
25.78%
|
14.99%
|
11.05%
|
66.88%
|
|
|
€
1.18M
|
€
1.01M
|
€
1.01M
|
€
61K
|
|
|
€
544K
|
€
131K
|
€
12K
|
€
50K
|
|
|
1
|
1
|
1
|
1
|
Publications 2
All publicationsFrequently asked questions
Answers to the most common questions about Ace Pharmaceuticals Belgium, based on official government data and the filed annual accounts.
What is the VAT number of Ace Pharmaceuticals Belgium?
The VAT number of Ace Pharmaceuticals Belgium is BE0732.788.379.
How many employees work at Ace Pharmaceuticals Belgium?
In 2025, Ace Pharmaceuticals Belgium employed 1.00 full-time equivalents (FTE).
When was Ace Pharmaceuticals Belgium established?
Ace Pharmaceuticals Belgium was founded in 22-08-2019.
What is the official address of Ace Pharmaceuticals Belgium?
The official address of Ace Pharmaceuticals Belgium is Xavier De Cocklaan 66/5 Sint-Martens-Latem 9831.
What is the legal form of Ace Pharmaceuticals Belgium?
The juridical form of Ace Pharmaceuticals Belgium is Private limited company (BV/SRL).
What is the annual revenue of Ace Pharmaceuticals Belgium?
The 2025 accounts of Ace Pharmaceuticals Belgium do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
Is Ace Pharmaceuticals Belgium a reliable company?
Ace Pharmaceuticals Belgium is a registered Rechtspersoon with company number 0732.788.379 and can be verified through the official CBE database.
What is the credit limit of Ace Pharmaceuticals Belgium?
The estimated credit limit of Ace Pharmaceuticals Belgium is €341,049.
Is Ace Pharmaceuticals Belgium still active?
Ace Pharmaceuticals Belgium currently has the status "Normal situation" and is active.